These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38074770)

  • 21. "Until people start dying in droves, no actions will be taken": perception and experience of HIV-preventive measures among people who inject drugs in northwestern Russia.
    Meylakhs P; Aasland A; Grønningsæter A
    Harm Reduct J; 2017 Jun; 14(1):33. PubMed ID: 28583120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A qualitative analysis of rural syringe service program fidelity in Appalachian Kentucky: Staff and participant perspectives.
    Batty EJ; Ibragimov U; Fadanelli M; Gross S; Cooper K; Klein E; Ballard AM; Young AM; Lockard AS; Oser CB; Cooper HLF
    J Rural Health; 2023 Mar; 39(2):328-337. PubMed ID: 36117151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China.
    Yang Y; Latkin CA; Luan R; Yang C
    BMC Public Health; 2015 Sep; 15():885. PubMed ID: 26370245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: a modelling study.
    Tan J; Altice FL; Madden LM; Zelenev A
    Lancet HIV; 2020 Feb; 7(2):e121-e128. PubMed ID: 31879250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of used syringe use and unsafe sex among people who inject drugs in Kumasi, Ghana: an urgent call for a comprehensive harm reduction approach.
    Messersmith LJ; Adjei R; Beard J; Bazzi AR; Earlywine JJ; Darko E; Agyarko-Poku T; Asafo MK; Bempah SA; Adu-Sarkodie Y
    Harm Reduct J; 2021 Jun; 18(1):62. PubMed ID: 34112187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with perceived ease of access to syringes in Appalachian North Carolina.
    Carpenter DM; Zule WA; Hennessy CM; Evon DM; Hurt CB; Ostrach B
    J Rural Health; 2023 Jan; 39(1):212-222. PubMed ID: 35819251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia.
    Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG
    Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of an mHealth App That Provides Harm Reduction Services Among People Who Inject Drugs: Survey Study.
    Shelby T; Zhou X; Barber D; Altice F
    J Med Internet Res; 2021 Jul; 23(7):e25428. PubMed ID: 34259640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
    Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
    Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
    Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
    Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs.
    Tookes HE; Oxner A; Serota DP; Alonso E; Metsch LR; Feaster DJ; Ucha J; Suarez E; Forrest DW; McCollister K; Rodriguez A; Kolber MA; Chueng TA; Zayas S; McCoy B; Sutherland K; Archer C; Bartholomew TS
    Trials; 2023 Feb; 24(1):96. PubMed ID: 36750867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling the impact and cost-effectiveness of non-governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine.
    Stone J; Trickey A; Walker JG; Bivegete S; Semchuk N; Sazonova Y; Varetska O; Altice FL; Saliuk T; Vickerman P
    J Int AIDS Soc; 2023 Apr; 26(4):e26073. PubMed ID: 37012669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "…because the social work never ends": a qualitative study exploring how NGOs responded to emerging needs while upholding responsibility to HIV prevention and treatment during the war in Ukraine.
    Lazarus L; McClarty LM; Herpai N; Pavlova D; Tarasova T; Gnatenko A; Bondar T; Lorway R; Becker ML;
    J Int AIDS Soc; 2024 Jul; 27 Suppl 3(Suppl 3):e26309. PubMed ID: 39030857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
    Cepeda JA; Eritsyan K; Vickerman P; Lyubimova A; Shegay M; Odinokova V; Beletsky L; Borquez A; Hickman M; Beyrer C; Martin NK
    Lancet HIV; 2018 Oct; 5(10):e578-e587. PubMed ID: 30033374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occupational roles and risks of community-embedded peer educators providing HIV, hepatitis C and harm reduction services to persons who inject drugs in Nairobi, Kenya.
    Masese LN; Ludwig-Barron NT; Mbogo L; Guthrie BL; Musyoki H; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
    PLoS One; 2022; 17(12):e0278210. PubMed ID: 36454881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities.
    Scheibe A; Shelly S; Lambert A; Schneider A; Basson R; Medeiros N; Padayachee K; Savva H; Hausler H
    Harm Reduct J; 2017 Jun; 14(1):35. PubMed ID: 28592246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
    McMullen TP; Naeim M; Newark C; Oliphant H; Suchard J; Banimahd F
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):27. PubMed ID: 33761954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 23 Metropolitan Statistical Areas, United States, 2018.
    Handanagic S; Finlayson T; Burnett JC; Broz D; Wejnert C;
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(42):1459-1465. PubMed ID: 34673746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them.
    Broz D; Carnes N; Chapin-Bardales J; Des Jarlais DC; Handanagic S; Jones CM; McClung RP; Asher AK
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S118-S129. PubMed ID: 34686281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.